Global export reach PharmaVision exports pharmaceuticals to over 30 countries, including EU members, indicating an established international footprint and potential for cross-border supply chain partnerships, contract manufacturing opportunities, and regional distribution collaborations.

Sustainability leadership The company operates with multiple environmental and safety certifications (ISO 14001, OHSAS 18001, ISO 50001, ISO 31000, ISO 17025, ISO 27001, ISO 27701) and a Responsible Care commitment, highlighting a strong sustainability and compliance story that resonates with partners prioritizing responsible sourcing and green manufacturing.

Long-standing capacity With roots dating back to 1954 and continuous activity since 1966, PharmaVision demonstrates proven manufacturing capabilities, reliability, and potential for scale-up, which is attractive for brands seeking trusted CDMO or private-label collaborations.

Digital foundations Technology stack includes iCIMS, Cloudflare, Google Analytics, and Microsoft-based infrastructure, signaling mature digital operations and potential for streamlined marketing/sales outreach, contract management, and data-driven partner engagements.

Growth focus sectors Revenue is in the high hundreds of millions to low billions, and the company serves local and international markets; combined with a quality-first approach, this presents opportunities in new therapeutic areas, regulatory file-ready partnerships, and expanded manufacturing services for both EU and non-EU markets.